Chemical industry – Page 85
-
Business
Ashland cuts jobs in global reshuffle
Speciality chemicals maker will axe 800-1000 positions and relocate 800-1000 more during 2014
-
Business
Jazz spending spree has ups and downs
Aerial sells Jazz rights to sleeping sickness drug but Gentium shareholders put brakes on earlier deal
-
Business
US blocks imports from fourth Ranbaxy plant
FDA bans import of active ingredients from factory in Toansa, India
-
Business
Novartis and DSM trim jobs
Novartis to close US manufacturing site, both companies restructuring Swiss operations
-
NewsCroatia's vaccines manufacturer left hanging as it enters administration
Lack of government investment puts national immunology institute in crisis
-
BusinessPlug and play redox enzymes
Technology profile: HydRegen is making cofactor-dependent catalysis cleaner
-
CareersBy royal appointment
The Royal Commission for the Exhibition of 1851 brings UK science and industry together through its industrial fellowship scheme. Philip Robinson reports
-
Business
US chemical spill contaminates water supplies
Life beginning to return to normal for locals after being without potable water for several days
-
News
Radical drug rule changes hit buffers in India
Oversight panel concludes government plan will increase bureaucracy
-
Business
Novartis in the spotlight in mis-selling investigations
Crackdown on pharma marketing continues with US and Japanese cases
-
Business
Deadly explosion at Japanese silicon plant
Five killed and several more injured at Mitsubishi Materials site
-
Business
Thermo Fisher to sell three analytical divisions to GE Healthcare
Deal will help the firm complete its ongoing takeover of Life Technologies
-
OpinionIs there a drug for that?
Derek Lowe ponders whether anything is truly ‘undruggable’ if we look in the right places
-
-
-
Business
EU chemical agency gives first hazardous substance authorisation
Rolls Royce given first approval to use substance linked to birth defects under controlled conditions
-
Business
Kemira now water-based after formic acid sale
Business sold to US agrichemical for €140 million
-
Business
AstraZeneca claims quashed in heartburn drug patent case
Nexium rival does not infringe on patent, court rules